Rodriguez Javier
Chief Executive Officer at DVA; Director at GILD
- Sold, on record
- $101M
- Dollars the filings state
- Form 4 sales
- 30
- Latest Jun 16, 2026
- Form 144 notices
- 4
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale DVANo planMay 10, 2023 2023
Sold 16,916 shares at $99.43 ($1.7M)
Rodriguez Javier, Chief Executive Officer
No 10b5-1 planSold 5.1% of holdings ($33.1M position)315,622 shares leftFirst sale on recordFollows a Form 144Filing
- 2 Form 144 notice DVANoticeFeb 26, 2024 +292 days
Filed to sell 75,000 shares ($9.5M)
Rodriguez Javier, Officer, Director
No 10b5-1 planFiling
- 3 Form 4 sale DVANo planFeb 27, 2024 +1 day
Sold 75,000 shares at $126.18 ($9.5M)
Rodriguez Javier, Chief Executive Officer
No 10b5-1 planSold 13.5% of holdings ($70.2M position)481,300 shares leftFollows a Form 144Filing
- 4 Form 144 notice DVANoticeAug 26, 2024 +181 days
Filed to sell 50,000 shares ($7.8M)
Rodriguez Javier, Officer
No 10b5-1 planFiling
- 5 Form 4 sale DVANo planAug 27, 2024 +1 day
Sold 40,119 shares at $155.93 ($6.3M)
Rodriguez Javier, Chief Executive Officer
No 10b5-1 planSold 4.3% of holdings ($146M position)897,716 shares leftFollows a Form 144Filing
- 6 Form 144 notice DVANoticeSep 13, 2024 +17 days
Filed to sell 50,000 shares ($8.3M)
Rodriguez Javier, Officer
No 10b5-1 plan1.2x usual sizeFiling
- 7 Form 4 sale DVANo planSep 16, 2024 +3 days
Sold 59,881 shares at $164.69 ($9.9M)
Rodriguez Javier, Chief Executive Officer
No 10b5-1 planSold 6.7% of holdings ($148M position)837,835 shares left1.5x usual sizeFollows a Form 144Filing
- 8 Form 4 sale DVANo planJun 16, 2026 +638 days
Sold 69,407 shares at $209.38 ($14.5M)
Rodriguez Javier, Chief Executive Officer
No 10b5-1 planSold 7.6% of holdings ($190M position)840,408 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (34)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 16, 2026 | Jun 17, 2026 | DVA | Chief Executive Officer | Form 4 sale | 69,407 | $14.5M | 7.6% | No plan | SEC |
| Sep 16, 2024 | Sep 17, 2024 | DVA | Chief Executive Officer | Form 4 sale | 59,881 | $9.9M | 6.7% | No plan | SEC |
| Sep 13, 2024 | Sep 16, 2024 | DVA | Officer | Form 144 notice | 50,000 | $8.3M | Notice | SEC | |
| Aug 27, 2024 | Aug 28, 2024 | DVA | Chief Executive Officer | Form 4 sale | 40,119 | $6.3M | 4.3% | No plan | SEC |
| Aug 26, 2024 | Aug 26, 2024 | DVA | Officer | Form 144 notice | 50,000 | $7.8M | Notice | SEC | |
| Feb 27, 2024 | Feb 28, 2024 | DVA | Chief Executive Officer | Form 4 sale | 75,000 | $9.5M | 13.5% | No plan | SEC |
| Feb 26, 2024 | Feb 26, 2024 | DVA | Officer, Director | Form 144 notice | 75,000 | $9.5M | Notice | SEC | |
| May 10, 2023 | May 12, 2023 | DVA | Chief Executive Officer | Form 4 sale | 16,916 | $1.7M | 5.1% | No plan | SEC |
| May 10, 2023 | May 10, 2023 | DVA | Officer | Form 144 notice | 16,916 | $1.7M | Notice | SEC | |
| May 5, 2021 | May 5, 2021 | DVA | Chief Executive Officer | Form 4 sale | 27,053 | $3.3M | 9.0% | Plan not stated | SEC |
| Jun 23, 2020 | Jun 25, 2020 | GILD | Director | Form 4 sale | 189 | $14k | 100.0% | Unusual | SEC |
| Dec 7, 2017 | Dec 11, 2017 | DVA | Chief Executive Officer, DKC | Form 4 sale | 22,532 | $1.5M | 18.7% | Plan not stated | SEC |
| May 15, 2017 | May 17, 2017 | DVA | CEO-Kidney Care | Form 4 sale | 1,294 | $86k | 1.3% | Plan not stated | SEC |
| May 16, 2016 | May 17, 2016 | DVA | CEO-Kidney Care | Form 4 sale | 36,466 | $2.8M | 36.2% | Unusual | SEC |
| Apr 11, 2016 | Apr 12, 2016 | DVA | CEO-Kidney Care | Form 4 sale | 89,912 | $6.6M | 47.2% | Unusual | SEC |
| May 15, 2015 | May 19, 2015 | DVA | CEO, Kidney Care | Form 4 sale | 36,466 | $3M | 26.6% | Unusual | SEC |
| Apr 27, 2015 | Apr 29, 2015 | DVA | CEO, Kidney Care | Form 4 sale | 20,946 | $1.8M | 24.6% | Plan not stated | SEC |
| Mar 12, 2015 | Mar 16, 2015 | DVA | CEO, Kidney Care | Form 4 sale | 2,803 | $223k | 4.2% | Plan not stated | SEC |
| May 15, 2014 | May 16, 2014 | DVA | CEO, Kidney Care | Form 4 sale | 7,000 | $473k | 9.8% | Plan not stated | SEC |
| Mar 5, 2014 | Mar 7, 2014 | DVA | President of DaVita | Form 4 sale | 27,663 | $1.9M | 28.0% | Unusual | SEC |
| Feb 13, 2014 | Feb 18, 2014 | DVA | President of DaVita | Form 4 sale | 85,210 | $5.6M | 54.5% | Unusual | SEC |
| May 15, 2013 | May 15, 2013 | DVA | President of DaVita | Form 4 sale | 3,500 | $455k | 8.9% | Plan not stated | SEC |
| Dec 14, 2012 | Dec 17, 2012 | DVA | President | Form 4 sale | 53,018 | $5.7M | 57.5% | Unusual | SEC |
| Aug 14, 2012 | Aug 16, 2012 | DVA | President of DaVita | Form 4 sale | 19,162 | $1.9M | 32.9% | Unusual | SEC |
| Aug 9, 2012 | Aug 13, 2012 | DVA | President of DaVita | Form 4 sale | 1,111 | $109k | 1.9% | Plan not stated | SEC |
| Aug 6, 2012 | Aug 8, 2012 | DVA | President of DaVita | Form 4 sale | 70,054 | $6.8M | 54.1% | Unusual | SEC |
| May 13, 2011 | May 17, 2011 | DVA | Senior Vice President | Form 4 sale | 50,781 | $4.3M | 51.0% | Unusual | SEC |
| Dec 9, 2010 | Dec 13, 2010 | DVA | Senior Vice President | Form 4 sale | 24,983 | $1.8M | 33.8% | Unusual | SEC |
| Dec 2, 2010 | Dec 6, 2010 | DVA | Senior Vice President | Form 4 sale | 49,311 | $3.7M | 40.0% | Unusual | SEC |
| Mar 23, 2010 | Mar 25, 2010 | DVA | Senior Vice President | Form 4 sale | 11,286 | $718k | 15.1% | Plan not stated | SEC |
| Mar 2, 2010 | Mar 4, 2010 | DVA | Senior Vice President | Form 4 sale | 46,000 | $2.9M | 42.1% | Unusual | SEC |
| Sep 8, 2009 | Sep 10, 2009 | DVA | Senior Vice President | Form 4 sale | 20,000 | $1.1M | 24.0% | Plan not stated | SEC |
| Dec 18, 2007 | Dec 20, 2007 | DVA | Senior Vice President | Form 4 sale | 12,750 | $727k | 35.8% | Unusual | SEC |
| Dec 10, 2007 | Dec 12, 2007 | DVA | Senior Vice President | Form 4 sale | 30,000 | $1.8M | 56.7% | Unusual | SEC |